Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy iTeos Therapeutics (ITOS) stocks in Canada
Learn how to easily invest in iTeos Therapeutics stocks.
iTeos Therapeutics is a biotechnology business based in the US. iTeos Therapeutics stocks (ITOS.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $26.4 – a decrease of 6.66% over the previous week. iTeos Therapeutics employs 74 staff and has a trailing 12-month revenue of around $104.3 million.
How to buy shares in iTeos Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ITOS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy iTeos Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in iTeos Therapeutics?
- iTeos Therapeutics shares summary
- Compare share dealing platforms
- Is iTeos Therapeutics stock a buy or sell?
- iTeos Therapeutics performance over time
- Are iTeos Therapeutics shares over-valued?
- iTeos Therapeutics's financials
- Does iTeos Therapeutics pay a dividend?
- Other common questions
iTeos Therapeutics stock price (NASDAQ:ITOS)Use our graph to track the performance of ITOS stocks over time.
iTeos Therapeutics shares at a glance
|Latest market close||$38.15|
|52-week range||$17.43 - $52.43|
|50-day moving average||$37.93|
|200-day moving average||$28.44|
|Wall St. target price||$50.20|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.40|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
iTeos Therapeutics price performance over time
|1 week (2022-01-12)||-6.66%|
|1 month (2021-12-17)||-11.69%|
|3 months (2021-10-19)||38.32%|
|6 months (2021-07-19)||58.63%|
|1 year (2021-01-19)||4.81%|
|2 years (2020-01-15)||N/A|
|3 years (2019-01-15)||N/A|
|5 years (2017-01-15)||N/A|
Is iTeos Therapeutics under- or over-valued?
Valuing iTeos Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of iTeos Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
iTeos Therapeutics's P/E ratio
iTeos Therapeutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 99x. In other words, iTeos Therapeutics shares trade at around 99x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
iTeos Therapeutics's EBITDA
iTeos Therapeutics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $17 million.
The EBITDA is a measure of a iTeos Therapeutics's overall financial performance and is widely used to measure a its profitability.
iTeos Therapeutics financials
|Revenue TTM||$104.3 million|
|Operating margin TTM||15.7%|
|Gross profit TTM||$0|
|Return on assets TTM||1.61%|
|Return on equity TTM||4.17%|
|Market capitalisation||$1.4 billion|
TTM: trailing 12 months
iTeos Therapeutics share dividends
We're not expecting iTeos Therapeutics to pay a dividend over the next 12 months.
iTeos Therapeutics overview
Iteos Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2a receptor that is an open-label Phase 1/2a clinical trial in adult patients; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2a clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Cambridge, Massachusetts. .
Stocks similar to iTeos Therapeutics
Frequently asked questions
iTeos Therapeutics in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Should We Be Cautious About iTeos Therapeutics, Inc.'s (NASDAQ:ITOS) ROE Of 4.0%?
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.